Günter NIEGISCH | Full Professor GU oncology | Professor | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU | Department of Urology
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial - The Lancet Oncology
Christian WÜLFING | Chief of Department | Prof. Dr. med. | Asklepios Klinik Altona, Hamburg | Department of Urology | Scientific profile
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - ScienceDirect
Prof.Dr. Özcan YILDIZ | Doktorlarımız | Medipol Sağlık Grubu
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit
Markus MOEHLER | Head Gastrointestinal Oncology / Senior Consultant Endosonography | Professor | Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz | I. Medical Clinic - Page 2
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (K
Mustafa Özgüroğlu - AD Scientific Index 2023
Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
István LÁNG | National Institute of Oncology, Budapest | Medical Oncology and Clinical Pharmachology "B"
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer
Fuat DEMIRELLI | Doctor of Medicine | İstanbul University-Cerrahpaşa, Istanbul | Department of Internal Medicine
Title of the study: Phase II Clinical Study Evaluating the Efficacy and Safety of Weekly Docetaxel and Four Weekly Carboplat
cocina acción Estable prof dr mustafa özgüroğlu muayenehanesi convertible lámpara Menstruación
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Turkish Society Of Medical Oncology
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit
Mustafa Özgüroğlu (mzgrolu) - Profile | Pinterest
